Deal kneads knee imaging

Perceptive Informatics has allied with Optasia Medical to enhance its medical imaging capabilities for osteoarthritis clinical trials. The e-clinical solutions provider is using Optasia's KneeAnalyzer software to supplement its existing medical-imaging technology in an effort to improve reproducibility and hasten image analysis of the knee in osteoarthritis patients.

The Optasia Platform uses model-based vision technology to detect, measure, classify and compare 2-D medical images. Medical imaging aids in the early evaluation of drug candidates for musculoskeletal-related clinical research, including rheumatoid arthritis, osteoporosis, and osteoarthritis, according to an announcement. The alliance is intended to improve surrogate measurements in trials focused on knee-related osteoarthritis.

Perceptive Informatics announced in July that it had joined with Biospective in a deal to enhance processing and analysis of medical images for central nervous system and oncology-related clinical trials, as reported earlier. 

- here's the announcement
- see our earlier coverage

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.